Abstract | AIM:
Lung cancer is the leading cause of cancer-related death worldwide. Interleukin-4 (IL-4) is a typical pleiotropic T helper 2 cytokine involved in immunology during carcinogenesis. The present study aimed at evaluating the contribution of IL-4 promoter T-1099G (rs2243248), C-589T (rs2243250), C-33T (rs2070874) genetic polymorphisms to the risk of lung cancer in Taiwan. MATERIALS AND METHODS: The contributions of the promoter IL-4 polymorphic genotypes to lung cancer risk were investigated in 358 lung cancer patients and 716 age- and gender-matched healthy controls. In addition, the interaction between IL-4 and individual smoking status was also evaluated. RESULTS: The percentages of CC, CT and TT for IL-4 C-589T genotypes were differentially represented as 69.0%, 26.5% and 4.5% in the lung-cancer patient group and 61.3%, 30.4% and 8.3% in the non- cancer control group, respectively (p=0.0156). The TT genotype carriers were of lower risk for lung cancer (odds ratio (OR)=0.48, 95% confidence interval (CI)=0.27-0.86, p=0.0106) than the CC genotype carriers. We also analyzed the allelic frequency distributions and the results showed that the T allele of IL-4 C-589T conducted a protective effect on lung cancer susceptibility (p=0.0022). On the contrary, there was no difference in the distribution of genotypic or allelic frequencies among patients and controls for the IL-4 promoter T-1099G and C-33T. CONCLUSION: The TT genotype of IL-4 C-589T compared to the CC wild-type genotype may have a protective effect on lung cancer risk in Taiwan and may serve as an early detection and prediction marker.
|
Authors | Wen-Shin Chang, Shou-Cheng Wang, Chin-Liang Chuang, Hong-Xue Ji, Chieh-Lun Hsiao, Chin-Mu Hsu, Chia-Wen Tsai, Shih-Ping Liu, Pei-Chen Hsu, Yen-Li Lo, Da-Tian Bau |
Journal | Anticancer research
(Anticancer Res)
Vol. 35
Issue 11
Pg. 6297-301
(Nov 2015)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 26504066
(Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright© 2015 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- IL10 protein, human
- Interleukin-10
|
Topics |
- Aged
- Case-Control Studies
- Female
- Follow-Up Studies
- Genetic Predisposition to Disease
- Genotype
- Humans
- Interleukin-10
(genetics)
- Lung Neoplasms
(genetics, pathology)
- Male
- Middle Aged
- Neoplasm Staging
- Polymorphism, Restriction Fragment Length
- Polymorphism, Single Nucleotide
(genetics)
- Prognosis
- Promoter Regions, Genetic
(genetics)
- Risk Factors
- Taiwan
|